NIAID
Day Zero Diagnostics Wins $300K SBIR Grant for Fecal Microbiota Transplant Assay
The Boston firm will develop a sequencing-based safety and efficacy assay for fecal microbiota transplants called epiXact FMT.
Phase Genomics Wins $5.5M in NIH, Gates Foundation Grants for Therapeutic Phage Discovery
The company will use its proximity-guided metagenomics platform to build an atlas of phage-bacteria interactions and identify phages that could be used therapeutically.
UCSF-led Team Wins $112M NIH Grant to Harness Omics Tools for Antiviral Target, Drug Development
Premium
The researchers will use a variety of omics tools, including a protein-protein interaction workflow they previously employed to look for drugs against SARS-CoV-2.
Sequencing Leads to Diagnoses in Significant Subset of Immune Conditions in NIAID Program
In the first 1,000 families tested through a sequencing-based program at the National Institute of Allergy and Infectious Diseases, researchers diagnosed almost a third of cases.
Evolution of Dengue Virus Antigens Reflected in Outbreaks in Thailand
An international team sequenced 1,944 dengue virus isolates collected in Bangkok over 20 years as part of an effort to follow DENV antigen evolution.